Ledger.Open graph →
SEC Form D · filed March 19, 2024

NEKTAR THERAPEUTICS

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Sandra W. Gardiner · San Francisco, CAExecDiana M. Brainard · San Francisco, CADirectorRobert B. Chess · San Francisco, CADirectorR. Scott M. Greer · San Francisco, CADirectorJonathan A. Zalevsky · San Francisco, CAExecRoy A. Whitfield · San Francisco, CADirectorMark A. Wilson · San Francisco, CAExecJeffrey R. Ajer · San Francisco, CADirectorHoward W. Robin · San Francisco, CAExec · DirectorRoy A. Whitfield · San Francisco, CADirectorMark A. Wilson · San Francisco, CAExecSandra W. Gardiner · San Francisco, CAExecJeffrey R. Ajer · San Francisco, CADirectorHoward W. Robin · San Francisco, CAExec · DirectorDiana M. Brainard · San Francisco, CADirectorRobert B. Chess · San Francisco, CADirectorR. Scott M. Greer · San Francisco, CADirectorJonathan A. Zalevsky · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗